tr2-ice
Age Range ≥16 Years, Gender Unlimited
Affiliated Hospital to Academy of Military Medical SciencesunclassifiedPhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Age Range ≥16 Years, Gender Unlimited cohort.
| Asset / Sponsor | Phase | Rating |
|---|
Same molecule, other indications
tr2-ice is also rated in:
Histopathology Confirmed Diffuse Large B-cell Lymphoma or High-grade B-cell LymphomaDormant
CCC
Indicative ·
53 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →